Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation
Mendoza, Manel (Hospital Universitari Vall d'Hebron)
Garcia-Manau, Pablo (Hospital Universitari Vall d'Hebron)
Arévalo, Silvia (Hospital Universitari Vall d'Hebron)
Avilés García, M. T (Hospital Universitari Vall d'Hebron)
Serrano, B. (Hospital Universitari Vall d'Hebron)
Sánchez-Durán, M. á. (Hospital Universitari Vall d'Hebron)
Garcia-Ruiz, Itziar (Hospital Universitari Vall d'Hebron)
Bonacina, Erika (Hospital Universitari Vall d'Hebron)
Carreras Moratonas, Elena (Hospital Universitari Vall d'Hebron)
Universitat Autònoma de Barcelona

Data:	2021
Resum:	To compare the ability of first-trimester combined screening for pre-eclampsia (PE) to predict early-onset and preterm PE when pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PlGF) were assessed before vs after 11 weeks' gestation. This was a secondary analysis of a prospective cohort study of singleton pregnancies undergoing routine first-trimester screening conducted at Vall d'Hebron University Hospital, Barcelona, Spain, between October 2015 and September 2017. Demographic characteristics, obstetric history, maternal history and biophysical markers (mean uterine artery pulsatility index and mean arterial blood pressure (MAP)) were recorded at the first-trimester scan (at 11 + 0 to 13 + 6 weeks' gestation). Maternal serum concentrations of PAPP-A and PlGF were assessed from the routine first-trimester blood test (at 8 + 0 to 13 + 6 weeks). Women were classified into two groups depending on whether serum biomarkers were assessed at 8 + 0 to 10 + 6 weeks or at 11 + 0 to 13 + 6 weeks. Probability scores for early-onset and preterm PE were calculated by using two different algorithms: the multivariate Gaussian-distribution model and The Fetal Medicine Foundation (FMF) competing-risks model. Receiver-operating-characteristics (ROC) curves were produced and detection rates at fixed 5% and 10% false-positive rates were computed to compare the performance of these algorithms when PAPP-A and PlGF were assessed before vs after 11 weeks. Of the 2641 women included, serum biomarkers were assessed before 11 weeks in 1675 (63. 4%) and at or after 11 weeks in 966 (36. 6%). Of these, 90 (3. 4%) women developed PE, including 11 (0. 4%) cases of early-onset PE and 30 (1. 1%) of preterm PE. Five (45. 5%) cases of early-onset and 16 (53. 3%) of preterm PE were identified in the group in which serum biomarkers were assessed at 8 + 0 to 10 + 6 weeks and six (54. 5%) cases of early-onset and 14 (46. 7%) of preterm PE in the group in which serum biomarkers were assessed at 11 + 0 to 13 + 6 weeks. In the prediction of early-onset and preterm PE using the Gaussian algorithm, no differences were observed between the areas under the ROC curves (AUCs) when PAPP-A and PlGF were measured before or after 11 weeks. In the prediction of early-onset and preterm PE using the FMF algorithm, no differences were observed between AUCs for any of the combinations used for risk calculation when the serum biomarkers were obtained before vs after 11 weeks, except for the combination of PAPP-A and MAP, which showed a greater AUC for the prediction of early-onset PE when PAPP-A was measured at or after 11 weeks. The prediction of early-onset and preterm PE is similar when serum biomarkers are measured before or after 11 weeks. This allows the use of a two-step approach for PE risk assessment that permits immediate risk calculation at the time of the first-trimester scan. © 2020 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, fins i tot amb finalitats comercials, sempre i quan es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Early-onset pre-eclampsia ; First-trimester ; PlGF ; Pre-eclampsia ; Screening ; Uterine artery Doppler
Publicat a:	Ultrasound in obstetrics & gynecology, Vol. 57 (january 2021) , p. 84-90, ISSN 1469-0705

DOI: 10.1002/uog.22071
PMID: 32388877

7 p, 122.5 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats